| Patent application number | Description | Published |
|---|
| 20100127008 | METHOD AND DEVICE FOR PRESSURIZING CONTAINERS - A container, such as a bottle or jar, that includes a closed compartment and an active insert device for pressurizing the closed compartment. The active insert device comprises an elastic liner and an active insert that are affixed to a closure or cap or the container. The active insert includes at least one reactant that is triggered to a reaction by an external energy source. The reaction produces a gas, which is delivered to the closed compartment via the liner. The gas causes the liner to expand and open a passage to deliver the gas to the closed compartment. | 05-27-2010 |
| 20110089058 | METHOD, CONTAINER AND CLOSURE FOR PRESSURIZING CONTAINERS WITH NITROGEN - A container comprising a compartment and a closure, which hermetically seals the compartment. The closure comprises an active insert device that comprises one or more reactants that when initiated enter into a diazotization reaction produces nitrogen gas which is delivered to the compartment to increase the pressure of the compartment. The active insert device includes a filter that filters the gas and a vent port through which the gas is delivered to the compartment. A seal opens and closes the vent port based on a pressure difference between the compartment and the vent port side of the seal. | 04-21-2011 |
| 20120108838 | SYNTHESIS OF AN ENERGETIC NITRATE ESTER - Preparation of an energetic nitrate ester compound and related intermediates is provided. | 05-03-2012 |
| 20130118123 | METHOD AND DEVICE FOR PRESSURIZING CONTAINERS - A container, such as a bottle or jar, that includes a closed compartment and an active insert device for pressurizing the closed compartment. The active insert device comprises an elastic liner and an active insert that are affixed to a closure or cap or the container. The active insert includes at least one reactant that is triggered to a reaction by an external energy source. The reaction produces a gas, which is delivered to the closed compartment via the liner. The gas causes the liner to expand and open a passage to deliver the gas to the closed compartment. | 05-16-2013 |
| 20130119009 | METHOD AND DEVICE FOR PRESSURIZING CONTAINERS - A container, such as a bottle or jar that includes a closed compartment and an active insert device for pressurizing the closed compartment. The active insert device comprises an elastic liner and an active insert that are affixed to a closure or cap or the container. The active insert includes at least one reactant that is triggered to a reaction by an external energy source. The reaction produces a gas, which is delivered to the closed compartment via the liner. The gas causes the liner to expand and open a passage to deliver the gas to the closed compartment. | 05-16-2013 |
| Patent application number | Description | Published |
|---|
| 20080281091 | Process for the Preparation of Porphyrin Derivatives as Antimicrobial Agents by Photodynamic Therapy (Pdt) - There is provided a process for the preparation of 5,15-bis-[4-(3-trimethylammonio-propyloxy)-phenyl]-porphyrin dihalide, wherein the process comprises step (a) of providing 4-(3-bromopropyloxy)benzaldehyde, step (b) of providing dipyrrolmethane, step (c) of reacting the 4-(3-bromopropyloxy)benzaldehyde with the dipyrrol-methane, together with trifluoro acetic acid, in the presence of an oxidation reagent to produce 5,15-bis-[4-(3-bromo-propyloxy)-phenyl]-porphyrin which is purified by Soxhlet extraction from the adsorbed state on a bed of alumina under highly controlled conditions; and step (d) of reacting the 5,15-bis-[4-(3-bromo-propyloxy)-phenyl]-porphyrin with trimethylamine in the presence of dry dimethylformamide to produce 5,15-bis-[4-(3-trimethylammonio-propyl-oxy)-phenyl]-porphyrin dibromide. In a preferred embodiment, the process further comprises step (e) of passing the 5,15-bis-[4-(3-trimethylammonio-propyloxy)-phenyl]-porphyrin dibromide produced in step (d) through an anion exchanger to produce 5,15-bis-[4-(3-trimethylammonio-propyloxy)-phenyl]-porphyrin dichloride. There is provided a process for the preparation of 5,15-bis-(4-{3-[(3-dimethylamino-propyl)-dimethyl-ammonio]-propyloxy}-phenyl]-porphyrin dihalide. | 11-13-2008 |
| 20090298869 | Crystalline pharmaceutical and methods of preparation and use thereof - Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention. | 12-03-2009 |
| 20120107404 | Crystalline Pharmaceutical and Methods of Preparation and Use Thereof - Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention. | 05-03-2012 |
| 20130144063 | Crystalline Pharmaceutical and Methods of Preparation and Use Thereof - Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention. | 06-06-2013 |
| 20150218135 | CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF - Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention. | 08-06-2015 |
